文献速递前列腺癌

雌激素与前列腺癌

Estrogens and prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2018-08-21

本文综述了雌激素在前列腺癌发生发展中的作用。雌激素来源包括合成、内源性、真菌和植物衍生化合物,通过膜相关受体和核雌激素受体影响基因表达。雌激素是前列腺癌发生和进展中被低估的因素,进一步研究可能发现环境影响因素和新治疗靶点。

要点

  • 雌激素是前列腺癌发生和进展中被低估的贡献因素。
  • 雌激素来源包括合成、内源性、真菌和植物衍生化合物。
  • 雌激素通过膜相关受体和核雌激素受体触发基因表达改变。

核心结论

  • 雌激素是前列腺癌发生和进展中被低估的因素,进一步研究可能提供环境影响因素识别和新治疗靶点的机会。

研究设计与样本

  • 本文为针对雌激素与前列腺癌相互作用的基础科学和临床证据的批判性文献综述。

主要发现

  • 雌激素影响前列腺癌的因素包括合成、内源性、真菌和植物衍生化合物。
  • 雌激素是一类性激素,可穿过疏水性细胞膜并结合膜相关受体和定位于细胞核的雌激素受体,触发不同器官系统的基因表达改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hormonal influences such as androgens and estrogens are known contributors in the development and progression of prostate cancer (CaP). While much of the research to the hormonal nature of CaP has focused on androgens, estrogens also have critical roles in CaP development, physiology as well as a potential therapeutic intervention. METHODS: In this review, we provide a critical literature review of the current basic science and clinical evidence for the interaction between estrogens and CaP. RESULTS: Estrogenic influences in CaP include synthetic, endogenous, fungi and plant-derived compounds, and represent a family of sex hormones, which cross hydrophobic cell membranes and bind to membrane-associated receptors and estrogen receptors that localize to the nucleus triggering changes in gene expression in various organ systems. CONCLUSIONS: Estrogens represent a under-recognized contributor in CaP development and progression. Further research in this topic may provide opportunities for identification of environmental influencers as well as providing novel therapeutic targets in the treatment of CaP.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Dobbs RW, Malhotra NR, Greenwald DT, et al. Estrogens and prostate cancer. Prostate Cancer Prostatic Dis. 2018. PMID: 30131606. doi:10.1038/s41391-018-0081-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。